(MNKD) MannKind - Performance -29.7% in 12m
MNKD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
29.35%
#13 in Peer-Group
Rel. Strength
18.11%
#6082 in Stock-Universe
Total Return 12m
-29.67%
#90 in Peer-Group
Total Return 5y
105.75%
#10 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 37.5 |
| P/E Forward | 25.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 7.44 USD |
| 52 Week Low | 3.58 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 14.40 |
| Buy/Sell Signal +-5 | -2.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MNKD (-29.7%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MNKD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MNKD
| Total Return (including Dividends) | MNKD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.55% | 2.27% | 4.52% |
| 3 Months | -27.68% | 6.30% | 10.43% |
| 12 Months | -29.67% | -10.68% | 14.67% |
| 5 Years | 105.75% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | MNKD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -78.2% | 5.5% | 79.1% |
| 3 Months | -85% | 74.3% | 94.2% |
| 12 Months | -60.5% | -84.7% | 44.4% |
| 5 Years | 55.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th13.00 | -18.41% | -20.16% |
| 3 Month | %th13.00 | -31.97% | -34.51% |
| 12 Month | %th55.50 | -21.26% | -38.67% |
| 5 Years | %th95.50 | 178.53% | -1.66% |
FAQs
Does MannKind (MNKD) outperform the market?
No,
over the last 12 months MNKD made -29.67%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months MNKD made -27.68%, while XBI made 6.30%.
Performance Comparison MNKD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MNKD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -12.1% | -21.1% | -52% | -44% |
| US NASDAQ 100 | QQQ | -11.6% | -21.2% | -53.3% | -44% |
| German DAX 40 | DAX | -10.4% | -15.5% | -63.5% | -58% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.1% | -20.7% | -53% | -47% |
| Hongkong Hang Seng | HSI | -10.3% | -22.6% | -69.8% | -66% |
| India NIFTY 50 | INDA | -12.2% | -18.9% | -50.3% | -30% |
| Brasil Bovespa | EWZ | -13.2% | -24.1% | -74.9% | -43% |
MNKD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -12.7% | -22.6% | -57.1% | -57% |
| Consumer Discretionary | XLY | -11.5% | -18.6% | -44.8% | -50% |
| Consumer Staples | XLP | -11.1% | -16.1% | -51.6% | -40% |
| Energy | XLE | -10.9% | -20.9% | -46% | -26% |
| Financial | XLF | -12.4% | -20.2% | -55.8% | -59% |
| Health Care | XLV | -12.5% | -20.1% | -46% | -26% |
| Industrial | XLI | -12.3% | -20.6% | -59.2% | -54% |
| Materials | XLB | -13% | -20.8% | -55.1% | -35% |
| Real Estate | XLRE | -9% | -17.2% | -50.9% | -43% |
| Technology | XLK | -11.8% | -24.5% | -54.3% | -41% |
| Utilities | XLU | -10.7% | -17% | -54.7% | -54% |
| Aerospace & Defense | XAR | -12.7% | -23.8% | -70.5% | -79% |
| Biotech | XBI | -9.4% | -18.8% | -36.5% | -19% |
| Homebuilder | XHB | -14.6% | -27% | -45.5% | -35% |
| Retail | XRT | -13.1% | -21% | -46.3% | -39% |
MNKD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -11.6% | -22.9% | -41.9% | -20% |
| Natural Gas | UNG | -3.3% | -6.1% | -34.6% | -21% |
| Gold | GLD | -10.7% | -15.2% | -71.1% | -72% |
| Silver | SLV | -10.7% | -20.2% | -67.3% | -52% |
| Copper | CPER | -13.2% | -20.5% | -70.4% | -45% |
MNKD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -11.1% | -20.1% | -48.2% | -32% |
| iShares High Yield Corp. Bond | HYG | -10.3% | -17.8% | -49.9% | -40% |